IL6 and breast cancer: In breast cancer, incessant activation of STAT3 appears to be attributable to the upregulation of the pro-inflammatory cytokine IL-6 and S1PR1 (Lee et al., 2010; Alshaker et al., 2014; Alshaker et al., 2015).